Files
statdx/docs_md/articles/adrenal-adenoma_e2916d86-5f9f-4dd3-9576-1a7b89d8dda0.md
Ross 9c86b32c3b .
2025-10-20 21:15:33 +01:00

36 KiB

title, docid, authors, breadcrumbs, category, documentVersionId, imageCount, lastUpdated, pageDescription, pageKeywords, pageTitle, enhancedTitle, type, references, tables, breadcrumbs
title docid authors breadcrumbs category documentVersionId imageCount lastUpdated pageDescription pageKeywords pageTitle enhancedTitle type references tables breadcrumbs
Adrenal Adenoma e2916d86-5f9f-4dd3-9576-1a7b89d8dda0
key value
c3463c5c-31d3-4489-bbfe-6b895abdb86d Mitchell Tublin, MD
key value
b1738976-d5a8-48bc-a435-ed1434cd451a Mark D. Sugi, MD
name slug treeNodeId
Genitourinary genitourinary bd0eb4fe-d465-4faa-a3b7-526e8f01802d
name slug treeNodeId
Diagnosis diagnosis e82a3e55-c0be-4ed1-acd6-b03ae9167c31
name slug treeNodeId
Adrenal adrenal d3b85dea-43cb-4be3-b103-902e38d0336e
name slug treeNodeId
Benign Neoplasms benign-neoplasms eeebc0ba-f71a-4ae6-8daf-525d0d18fa16
name slug treeNodeId
Adrenal Adenoma adrenal-adenoma null
Genitourinary 8ad724c2-555b-4bbf-8716-75f7b7b7c611 23 10/04/21 Adrenal Adenoma Genitourinary, Diagnosis, Adrenal, Benign Neoplasms, Adrenal Adenoma Adrenal Adenoma | STATdx Adrenal Adenoma DX true 1
Genitourinary
Diagnosis
Adrenal
Benign Neoplasms
Adrenal Adenoma

title: "Adrenal Adenoma" docid: "e2916d86-5f9f-4dd3-9576-1a7b89d8dda0" authors:

  • key: "c3463c5c-31d3-4489-bbfe-6b895abdb86d" value: "Mitchell Tublin, MD"
  • key: "b1738976-d5a8-48bc-a435-ed1434cd451a" value: "Mark D. Sugi, MD" breadcrumbs:
  • name: "Genitourinary" slug: "genitourinary" treeNodeId: "bd0eb4fe-d465-4faa-a3b7-526e8f01802d"
  • name: "Diagnosis" slug: "diagnosis" treeNodeId: "e82a3e55-c0be-4ed1-acd6-b03ae9167c31"
  • name: "Adrenal" slug: "adrenal" treeNodeId: "d3b85dea-43cb-4be3-b103-902e38d0336e"
  • name: "Benign Neoplasms" slug: "benign-neoplasms" treeNodeId: "eeebc0ba-f71a-4ae6-8daf-525d0d18fa16"
  • name: "Adrenal Adenoma" slug: "adrenal-adenoma" treeNodeId: null category: "Genitourinary" documentVersionId: "8ad724c2-555b-4bbf-8716-75f7b7b7c611" imageCount: 23 lastUpdated: "10/04/21" pageDescription: "Adrenal Adenoma" pageKeywords: "Genitourinary, Diagnosis, Adrenal, Benign Neoplasms, Adrenal Adenoma" pageTitle: "Adrenal Adenoma | STATdx" enhancedTitle: "Adrenal Adenoma" type: "DX" references: true tables: 1 breadcrumbs:
  • "Genitourinary"
  • "Diagnosis"
  • "Adrenal"
  • "Benign Neoplasms"
  • "Adrenal Adenoma"

KEY FACTS

  • Imaging

    • Well-circumscribed, uniform, low-attenuation, small adrenal mass - Low attenuation due to abundant intracytoplasmic lipid - Imaging features of typical lipid-rich adenomas - NECT: < 10 HU (71% sensitivity, 98% specificity) - MR: Significant decrease in signal on out-of-phase T1WI due to intravoxel lipid and water - May show focal areas of heterogeneous attenuation or absence of signal loss due to degeneration, hemorrhage, and fibrin deposition - Clinical context key to differentiate from collision tumor: Unlikely in absence of extraadrenal malignancy - Lipid-poor adenomas (10-40% cases): Utilize relative or absolute CT contrast washout kinetics for diagnosis
    • Accounts for vast majority of adrenal "incidentalomas" - Imaging intensive algorithm suggested for incidental adrenal lesions, though overwhelming majority are benign and hormonally inactive - Primary hyperaldosteronism (Conn syndrome): 80% due to unilateral, typically small (< 2 cm) adenoma - Cushing syndrome: 80-85% due to adrenal hyperplasia
    • Typically shows FDG uptake < that of liver on PET/CT
  • Top Differential Diagnoses

    • Adrenal metastases and lymphoma
    • Adrenal (macronodular) hyperplasia
    • Pheochromocytoma
    • Adrenal carcinoma
    • Adrenal myelolipoma
    • Gastric diverticulum
    • Adrenal cyst
  • Diagnostic Checklist

    • Asymptomatic mass: Usually nonfunctioning adenoma, even in patients with known cancer
    • NECT and MR are equally accurate for diagnosis of lipid-rich adenoma
    • Utilize dedicated CECT adrenal protocol with 15-minute delayed imaging for diagnosis of potential lipid-poor adenomas

TERMINOLOGY

  • Definitions

    • Benign adrenal cortical tumor

IMAGING

  • General Features

    • Best diagnostic clue

      - Imaging strategies target typical adenoma histology: Abundant intracytoplasmic lipid
              - Low attenuation (< 10 HU) on NECT
              - Significant loss of signal on out-of-phase T1WI MR (intravoxel fat and water)
      
    • Size

      - Cushing syndrome adenoma: 2-5 cm
      - Conn syndrome adenoma: Classically < 2 cm (20% < 1 cm)
      - Vast majority of incidental, hormonally inactive adrenal adenomas are small (< 2 cm)
      
    • Morphology

      - Usually round to oval suprarenal mass
      
    • Key concepts - Most common adrenal cortex tumor (10% bilateral) - Accounts for > 90% of all "incidentalomas" - May occur in up to 9% of general population, diagnosed on 5% of CT exams with various indications - Lipid-rich adrenal adenoma: 60-90% of adenomas - Lipid-poor adrenal adenoma: 10-40% of adenomas - Increased incidence in patients with diabetes and hypertension - NECT (or chemical shift MR): Study of choice to diagnose incidental adrenal masses - Classified into 2 types based on function - Nonhyperfunctioning: Normal hormone levels - Hyperfunctioning: Primary hyperaldosteronism, Cushing syndrome, hyperandrogenism - Cushing syndrome - 15-25% of cases are due to autonomous adrenal adenoma - 80-85% of cases are due toadrenal hyperplasia - Adenomas usually > 2 cm - Primary hyperaldosteronism (Conn syndrome) - 80% of cases are due to****adrenal adenoma - 20% of cases are due to adrenal hyperplasia - Adenomas are often small (< 2 cm)

  • CT Findings

    • NECT

      - Smooth, well defined, round or oval in shape
      - Homogeneous soft tissue mass of 0-20 HU
      - **Lipid-rich adrenal adenoma** (60-90% of cases)
              - Uniform low attenuation
                        - Metaanalysis of < 10 HU threshold: 71% sensitivity, 98% specificity
                        - Sensitivity may increase to almost 90% with histogram analysis (identify negative pixels), though variable results and scanner dependent
      - **Lipid-poor adrenal adenoma** (10-40% of cases)
              - Attenuation varies from 10-30 HU
              - Difficult to differentiate from metastases on NECT
      - Cushing syndrome due to adrenal adenoma
              - Remainder of ipsilateral gland and contralateral adrenal gland may be atrophic due to ↓ ACTH levels
              - ↑ cortisol: Feedback inhibition on pituitary ACTH
      - ACTH-independent macronodular hyperplasia: Multiple, bilateral, functioning adrenal adenomas
      - Conn syndrome due to adrenal adenoma
              - Remainder of ipsilateral gland and contralateral adrenal gland appear normal
      - Large adenomas
              - More heterogeneous than small adenomas
              - ± hemorrhage, cystic degeneration, calcification
                        - Growth should raise suspicion for malignancy
      
    • CECT

      - Enhancing adrenal mass that deenhances rapidly
              - Dedicated adrenal CT exam incorporates initial dynamic enhanced phase (~ 70-second delay) and 15-minute delay
              - Relative percentage washout = dynamic enhanced (HU) - delayed (HU) / dynamic enhanced HU
                        - Relative percentage washout > 40%: 96% sensitivity, 100% specificity
              - Absolute percentage washout (if NECT available) = dynamic enhanced (HU) - delayed (HU) / dynamic enhanced (HU) - unenhanced (HU)
                        - Absolute percentage washout > 60%: 86-88% sensitivity, 92-96% specificity
              - 10-minute delay utilized by some centers, but shorter delay may decrease sensitivity
              - Adrenal washout calculators readily available online
              - Utilize technique for indeterminate, potentially lipid-poor adenomas
              - Clinical context critical: Rapid washout can be seen with pheochromocytomas, renal cell, hepatocellular carcinoma, and hypervascular metastases
      - Dual-energy CT and iodine subtraction techniques can generate virtual noncontrast (VNC) images
              - May identify lipid-rich adenomas and obviate need for additional imaging
              - Iodine:VNC ratio ≥ 6.7 has sensitivity and specificity of 95% for adenoma (higher ratios in adenoma compared to metastasis)
      
  • MR Findings

    • T1WI and T2WI - Low to intermediate signal
    • Chemical shift (in- and out-of-phase) imaging - Mainstay of MR diagnosis - Sensitivity and specificity equivalent to NECT - Signal loss on out-of-phase T1WI due to intravoxel water and fat protons - Inverse relationship between percentage of lipid-rich cells and relative ↓ signal on out-of-phase imaging - May not identify lipid-poor adenomas - Visual inspection of signal in phase (SIP) and out of phase (SOP), though quantitative analysis may be helpful - Adrenal to spleen chemical shift imaging (CSI) ratio: Lesion:spleen SOP/adrenal/spleen SIP - < .71 = adenoma - Adrenal signal intensity index: 100 x (SIP - SOP) / SIP - > 16.5% = adenoma - Beware technical pitfalls - Sampling of 1st echo pair at 3T is challenging - India ink artifact mimics signal loss, particularly in small adrenal lesions - Other primary or secondary adrenal lesions may contain lipid - Adenomas and metastases may coexist in same gland (collision tumor)
    • T1 C+ MR - Rapid, uniform enhancement and deenhancement
    • Ancillary MR techniques - Diffusion MR: Not specific (ADC overlap between adenomas and metastases) - MR spectroscopy: Choline:creatinine and choline:lipid ratio discriminatory threshold ratios may aid in adrenal lesion characterization, though larger studies needed
  • Ultrasonographic Findings

    • Grayscale ultrasound

      - Nonspecific, solid suprarenal mass
              - Right suprarenal mass seen more clearly left due to acoustic window provided by liver
      
  • Angiographic Findings

    • Conventional - Adrenal arteriography - Catheterization of renal or inferior adrenal arteries shows vascular supply of adrenal tumors - Adenomas are usually hypo- to moderately vascular - No arterial encasement or venous laking or puddling, which are malignant vascular features - Adrenal venography - Most commonly to obtain adrenal vein samples - Advocated for patients with primary hyperaldosteronism triaged to adrenalectomy - Technically difficult study but may confirm laterality of small, aldosterone-secreting adenoma - Technical approach and criteria for positive study varies; ACTH stimulation may increase accuracy - Adrenal adenoma is seen as filling defect within adrenal gland displacing adjacent vessels - Circumferential vein frequently seen around adrenal adenoma
  • Nuclear Medicine Findings

    • PET/CT - Utilized as part of malignancy staging - Markedly increased F-18 FDG uptake characteristic of metastases - Adenomas may also accumulate F-18 FDG, typically less intense than liver - Potential false-negatives: Metastases from primary carcinomas that are non-FDG avid (e.g., neuroendocrine tumors) - SUV thresholds published but adenomas typically less intense than liver
    • Adrenocortical scintigraphy by using NP-59 - NP-59 is cholesterol analog that binds to low-density lipoprotein receptors of adrenal cortex - NP-59 used and dexamethasone: Accentuate uptake in non-ACTH-dependent adrenal tissues (adenoma) - Normal NP-59: When both adrenal glands are seen 5 days after injection or thereafter - Adrenal adenoma: Unilateral early adrenal visualization before day 5 after NP-59 injection - Adrenal hyperplasia: Bilateral early adrenal visualization before day 5 after NP-59 injection
  • Imaging Recommendations

    • NECT is initial study of choice to confirm diagnosis of lipid-rich adrenal adenoma - ROI should encompass lesion: Attenuation < 10 HU is diagnostic
    • In- and out-of-phase MR equivalent to NECT for lipid-rich lesions - Signal dropout on out-of-phase T1WI MR: Qualitative assessment typically suffices
    • CECT, including 15-minute delayed phase, used for potential lipid-poor adenomas: Calculate either relative or absolute washout

DIFFERENTIAL DIAGNOSIS

  • Adrenal Metastases and Lymphoma

    • Adrenal metastases - Unilateral or bilateral masses ± central necrosis, hemorrhage - Usually known to have malignancy elsewhere - NECT: Metastases mimic lipid-poor adenoma - CECT: Hypo- or hypervascular and prolonged washout pattern
    • Adrenal lymphoma - Usually spread to adrenal gland from retroperitoneal tumor - Unilateral or bilateral masses - Unilateral primary lymphoma (non-Hodgkin) can mimic adenoma - Hypovascular; moderate enhancement with contrast
  • Adrenal Myelolipoma

    • Small or large, asymptomatic adrenal mass
    • Intramural macroscopic fatty elements on imaging
  • Adrenal Hyperplasia

    • Adrenal glands are often symmetrically enlarged
    • Width of adrenal gland limbs > 10 mm (diagnostic)
    • No discrete mass or nodule seen as rule
    • Dominant macronodule of macronodular hyperplasia mimics small adrenal adenomas - Cortisol-secreting adenoma: Remainder of ipsilateral and contralateral glands, atrophic (↓ ACTH) - Macronodular hyperplasia: Both glands are enlarged (due to elevated ACTH levels)
    • No obvious enhancement and washout pattern seen
  • Pheochromocytoma

    • Tumor > 3 cm in most cases; classically T2 hyperintense
    • Highly vascular tumor prone to hemorrhage, necrosis
    • Bilateral adrenal tumors in multiple endocrine neoplasia (MEN) syndromes
  • Unilateral Adrenal Hemorrhage

    • Chronic hematoma: Well-defined, round, low-density, mass-like lesion simulating adenoma
  • Adrenal Carcinoma

    • Rare, unilateral, invasive and enhancing mass
    • 6 cm when initially diagnosed

  • Gastric Diverticulum

    • Abnormal, rounded soft tissue lesion in left suprarenal area; mimics adrenal mass
    • Diverticular contents do not enhance, whereas adenomas do
    • Distend stomach with gas and fluid; scan in prone position to distend diverticulum
  • Ganglioneuroma

    • Younger patients; mean age: 27 years
    • Larger mass; average tumor size: 8 cm
  • Adrenal Cyst

    • Attenuation similar to lipid-rich adenoma
    • Lack of enhancement, rim calcification may suggest diagnosis

PATHOLOGY

  • General Features

    • Etiology

      - Unknown
      
    • Associated abnormalities

      - MEN syndromes
      - Most adrenals with adenoma have normal function
              - Occasionally adenoma causes adrenal hyperfunction
      - Normal adrenocortical secretory hormones
              - Cortisol, aldosterone, androgens
      
  • Gross Pathologic & Surgical Features

    • Well-delineated, tan-yellow, ovoid mass
    • 3 microscopic patterns - Pure (fasciculata- or reticularis-type cells), mixed, or hybrid
    • May have focal areas of degeneration, hemorrhage, and fibrin deposition
  • Microscopic Features

    • 70% of adenomas: High % of intracytoplasmic lipid
    • 30% of adenomas: Low % of intracytoplasmic lipid

CLINICAL ISSUES

  • Presentation

    • Most common signs/symptoms

      - Asymptomatic incidental CT finding
      - Conn syndrome: Hypertension and weakness
      - Cushing syndrome: Moon facies, truncal obesity, purple striae, and buffalo hump
      - Virilization in women
      - Lab data: ↑ aldosterone, cortisol, &/or androgens
      - Diagnosis: Clinical, biochemical, imaging, histology
      
  • Demographics

    • Age

      - Prevalence of adenoma increases with age
              - Peak at 60-69 years, decreasing thereafter
      
    • Epidemiology

      - Most common adrenal tumor of all incidentalomas
      - ↑ incidence in patients with diabetes or hypertension
      - Occurs in up to 9% of population (postmortem data)
      
  • Natural History & Prognosis

    • Prognosis: Excellent when incidental and nonhyperfunctioning
  • Treatment

    • No treatment when asymptomatic incidental finding
    • Laparoscopic removal of gland if hyperfunctioning

DIAGNOSTIC CHECKLIST

  • Consider

    • Asymptomatic mass: Usually nonhyperfunctioning adenoma, even in patient with known cancer
  • Image Interpretation Pearls

    • Well-defined, low-density (< 10 HU) suprarenal mass
    • Enhances with washout pattern > 50% within 15 minutes
    • Out-of-phase T1WI MR: Signal dropout, lipid-rich mass

00eaacf1-f275-4da9-8c9b-128eb7c97fee

References

Selected References

  1. Nagayama Y et al: Adrenal adenomas versus metastases: diagnostic performance of dual-energy spectral CT virtual noncontrast imaging and iodine maps. Radiology. 296(2):324-32, 2020
  2. Corwin MT et al: Differences in growth rate on CT of adrenal adenomas and malignant adrenal nodules. AJR Am J Roentgenol. 213(3):632-6, 2019
  3. Elbanan MG et al: Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics. Abdom Radiol (NY). 45(4):905-16, 2020
  4. Hekimsoy İ et al: Characterization of adrenal lesions on chemical shift MRI: comparison of 1.5 T and 3 T MRI. Abdom Radiol (NY). 44(10):3359-69, 2019
  5. Liu T et al: Distinguishing adrenal adenomas from non-adenomas with multidetector CT: evaluation of percentage washout values at a short time delay triphasic enhanced CT. Br J Radiol. 92(1094):20180429, 2019
  6. Platzek I et al: Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis. Eur Radiol. 29(2):806-17, 2019
  7. Humbert AL et al: The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas. Endocrine. 59(3):529-37, 2018
  8. Mohammed MF et al: Pheochromocytomas versus adenoma: role of venous phase CT enhancement. AJR Am J Roentgenol. 210(5):1073-8, 2018
  9. Rocha TO et al: Histogram analysis of adrenal lesions with a single measurement for 10th percentile: feasibility and incremental value for diagnosing adenomas. AJR Am J Roentgenol. 211(6):1227-33, 2018
  10. Thomas AJ et al: Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography. Abdom Radiol (NY). 43(11):3101-8, 2018
  11. Tu W et al: Can adrenal adenomas be differentiated from adrenal metastases at single-phase contrast-enhanced CT? AJR Am J Roentgenol. 211(5):1044-50, 2018
  12. Woo S et al: Pheochromocytoma as a frequent false-positive in adrenal washout CT: a systematic review and meta-analysis. Eur Radiol. 28(3):1027-36, 2018
  13. Mosconi C et al: Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT predictive score. AJR Am J Roentgenol. 209(1):122-9, 2017
  14. Schieda N et al: Update on CT and MRI of adrenal nodules. AJR Am J Roentgenol. 1-12, 2017
  15. Wagner-Bartak NA et al: Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation. AJR Am J Roentgenol. 209(1):19-32, 2017
  16. Diolombi ML et al: Diagnostic dilemmas in enlarged and diffusely hemorrhagic adrenal glands. Hum Pathol. 53:63-72, 2016
  17. Warda MH et al: Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas. Clin Imaging. 40(4):780-7, 2016
  18. Mileto A et al: Dual-energy multidetector CT for the characterization of incidental adrenal nodules: diagnostic performance of contrast-enhanced material density analysis. Radiology. 274(2):445-54, 2015
  19. Koo HJ et al: The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging. Eur Radiol. 24(6):1410-20, 2014
  20. Lattin GE Jr et al: From the radiologic pathology archives: adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation. Radiographics. 34(3):805-29, 2014
  21. Sebro R et al: Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT. Abdom Imaging. 40(2):318-26 2014
  22. Seo JM et al: Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol. 202(5):1043-50, 2014
  23. Kim YK et al: Adenoma characterization: adrenal protocol with dual-energy CT. Radiology. 267(1):155-63, 2013
  24. Northcutt BG et al: MDCT of adrenal masses: can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma? AJR Am J Roentgenol. 201(4):834-9, 2013
  25. Patel J et al: Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma? AJR Am J Roentgenol. 201(1):122-7, 2013
  26. Nakamura S et al: Characterization of adrenal lesions using chemical shift MRI: comparison between 1.5 Tesla and two echo time pair selection at 3.0 Tesla MRI. J Magn Reson Imaging. 35(1):95-102, 2012
  27. Blake MA et al: Adrenal imaging. AJR Am J Roentgenol. 194(6):1450-60, 2010

Tables

Washout Criteria/Enhancement Kinetics of Adrenal Adenoma

Absolute Washout Relative Washout Exceptions
[(Post HU - delayed HU) / (post HU - pre HU)] x 100 [(Post HU - delayed HU) / post HU] x 100 Significant minority of pheochromocytomas meet washout criteria for adenoma (25-33%) but rarely contain intracytoplasmic lipid
≥ 60% highly suggestive of adenoma ≥ 40% highly suggestive of adenoma Noncontrast attenuation (HU) ≥ 43 in adrenal mass without hemorrhage or calcification should raise suspicion for malignancy

Images

Selected Images

Axial in-phase T1 MR in a 77-year-old man with urothelial cancer shows a relatively homogeneous, 4.2-cm right adrenal mass . Axial in-phase T1 MR in a 77-year-old man with urothelial cancer shows a relatively homogeneous, 4.2-cm right adrenal mass .

Axial in-phase T1 MR in a 77-year-old man with urothelial cancer shows a relatively homogeneous, 4.2-cm right adrenal mass . Axial in-phase T1 MR in a 77-year-old man with urothelial cancer shows a relatively homogeneous, 4.2-cm right adrenal mass .

Axial out-of-phase T1 MR in the same patient shows marked signal loss in the adrenal mass , indicating intracytoplasmic lipid and consistent with adrenal adenoma. Axial out-of-phase T1 MR in the same patient shows marked signal loss in the adrenal mass , indicating intracytoplasmic lipid and consistent with adrenal adenoma.

Axial CECT in the same patient shows heterogeneous enhancement of the right adrenal mass  (75 HU), indeterminate on single-phase CT. Axial CECT in the same patient shows heterogeneous enhancement of the right adrenal mass (75 HU), indeterminate on single-phase CT.

Axial PET/CT in the same patient shows mild uptake in the right adrenal mass , less than that of the adjacent hepatic parenchyma , further supporting the diagnosis of adenoma made on MR. Axial PET/CT in the same patient shows mild uptake in the right adrenal mass , less than that of the adjacent hepatic parenchyma , further supporting the diagnosis of adenoma made on MR.

Axial in-phase T1 MR shows a mildly heterogeneous right adrenal mass  in a 62-year-old woman with hirsutism. Axial in-phase T1 MR shows a mildly heterogeneous right adrenal mass in a 62-year-old woman with hirsutism.

Axial out-of-phase T1 MR shows signal dropout at the periphery of the mass  and in the liver , indicating intracellular lipid. The mass was resected based on indeterminate imaging features and shown to be an adenoma with central degeneration, which can be seen with adenomas and can be confused with a collision tumor. Axial out-of-phase T1 MR shows signal dropout at the periphery of the mass and in the liver , indicating intracellular lipid. The mass was resected based on indeterminate imaging features and shown to be an adenoma with central degeneration, which can be seen with adenomas and can be confused with a collision tumor.

Coronal T1 MR in a 34-year-old woman with hypertension and hypokalemia shows an intermediate-signal left adrenal lesion . Note the incidental high-signal right renal cyst . Coronal T1 MR in a 34-year-old woman with hypertension and hypokalemia shows an intermediate-signal left adrenal lesion . Note the incidental high-signal right renal cyst .

Coronal out-of-phase T1 MR shows marked signal suppression of the left adrenal lesion, confirming a clinically functional, imaging apparent, lipid-rich adenoma . Signal suppression is due to intravoxel cytoplasmic lipid and water. Aldosterone-secreting adenomas are typically small (< 2 cm). Coronal out-of-phase T1 MR shows marked signal suppression of the left adrenal lesion, confirming a clinically functional, imaging apparent, lipid-rich adenoma . Signal suppression is due to intravoxel cytoplasmic lipid and water. Aldosterone-secreting adenomas are typically small (< 2 cm).

Axial NECT in the same patient shows a 1.5-cm, low-attenuation (5 HU), lipid-rich left adrenal adenoma . Axial NECT in the same patient shows a 1.5-cm, low-attenuation (5 HU), lipid-rich left adrenal adenoma .

Adrenal vein sampling was subsequently performed, which confirmed an aldosterone-secreting left adrenal lesion. Gross photo of the laparoscopically resected left adrenal gland shows an exophytic, well-circumscribed adrenocortical adenoma . Adrenal vein sampling was subsequently performed, which confirmed an aldosterone-secreting left adrenal lesion. Gross photo of the laparoscopically resected left adrenal gland shows an exophytic, well-circumscribed adrenocortical adenoma .

Coronal T1 MR of the lumbar spine in a 67-year-old woman shows an incidental, low-signal left adrenal mass . Coronal T1 MR of the lumbar spine in a 67-year-old woman shows an incidental, low-signal left adrenal mass .

Coronal NECT in the same patient shows low attenuation of the left adrenal mass  (HU -7). Noncontrast attenuation of HU < 10 is consistent with adrenal adenoma. Coronal NECT in the same patient shows low attenuation of the left adrenal mass (HU -7). Noncontrast attenuation of HU < 10 is consistent with adrenal adenoma.

Coronal portal venous-phase CT in the same patient shows mild enhancement of the left adrenal mass  (HU 73). Coronal portal venous-phase CT in the same patient shows mild enhancement of the left adrenal mass (HU 73).

Coronal 15-minute delayed-phase CECT shows washout of the left adrenal mass (HU 36) with relative washout of 51%, highly suggestive of an adrenal adenoma . Biochemical work-up, including metanephrines, performed due to the size of the mass was normal. Coronal 15-minute delayed-phase CECT shows washout of the left adrenal mass (HU 36) with relative washout of 51%, highly suggestive of an adrenal adenoma . Biochemical work-up, including metanephrines, performed due to the size of the mass was normal.

Axial in-phase T1 MR in a 68-year-old woman with colon cancer shows a mildly heterogeneous left adrenal mass . Axial in-phase T1 MR in a 68-year-old woman with colon cancer shows a mildly heterogeneous left adrenal mass .

Axial out-of-phase T1 MR in the same patient shows diffuse signal loss in the left adrenal mass , consistent with intracytoplasmic lipid in an adrenal adenoma. The mass remained stable over 4 years since incidental detection on initial surveillance imaging. Axial out-of-phase T1 MR in the same patient shows diffuse signal loss in the left adrenal mass , consistent with intracytoplasmic lipid in an adrenal adenoma. The mass remained stable over 4 years since incidental detection on initial surveillance imaging.

Additional Images

Axial CECT in a 68-year-old woman with colon cancer shows an indeterminate-signal, heterogeneous left adrenal mass  (HU 65) with relatively low central attenuation. Axial CECT in a 68-year-old woman with colon cancer shows an indeterminate-signal, heterogeneous left adrenal mass (HU 65) with relatively low central attenuation.

Axial T2 FS MR in the same patient shows low signal at the periphery of the mass  and increased signal centrally. Central degeneration, hemorrhage, and fibrosis are known features of some adrenal adenomas. The mass demonstrated diffuse signal loss on out-of-phase MR, consistent with intracellular lipid and adenoma. Axial T2 FS MR in the same patient shows low signal at the periphery of the mass and increased signal centrally. Central degeneration, hemorrhage, and fibrosis are known features of some adrenal adenomas. The mass demonstrated diffuse signal loss on out-of-phase MR, consistent with intracellular lipid and adenoma.

Axial NECT in a 34-year-old woman with elevated 24-hour urine cortisol and Cushing syndrome shows a low-attenuation (HU -6) right adrenal mass , confirmed to be an adrenal adenoma at surgical pathology. Axial NECT in a 34-year-old woman with elevated 24-hour urine cortisol and Cushing syndrome shows a low-attenuation (HU -6) right adrenal mass , confirmed to be an adrenal adenoma at surgical pathology.

Axial in-phase T1 MR shows small, bilateral adrenal masses . Axial in-phase T1 MR shows small, bilateral adrenal masses .

Axial opposed-phase T1 MR shows a loss of signal in both adenomas, confirming the presence of lipid. Axial opposed-phase T1 MR shows a loss of signal in both adenomas, confirming the presence of lipid.

Axial NECT shows a homogeneous, low-density right adrenal adenoma    and a normal left adrenal gland. Axial NECT shows a homogeneous, low-density right adrenal adenoma and a normal left adrenal gland.

Axial NECT shows a homogeneous, low-density adenoma that is larger than typical, which had grown slowly over 10 years. Axial NECT shows a homogeneous, low-density adenoma that is larger than typical, which had grown slowly over 10 years.